Tuomo Nikula

The Radiopharmaceuticals Specialist

Dr. Tuomo Nikula is a radio-chemist and cell biologist by education and has worked for many years for leading international clinical and nuclear institutions, such as Memorial Sloan Kettering Cancer Center, the Finish government and the Institute for Transuranium Elements (ITU) in various functions related to radio-immuno therapies and isotope production. He founded MAP Medical Technologies OY with others in Finland; a company specialized in the production and sale of radioisotopes. In 2002 MAP was sold to Schering OY, Finland. In the year 1998 Dr. Nikula already joined the Institute of Transuranium Elements (ITU) of the European Commission in Karlsruhe supporting several leading European Medical Research Institutions, such as the Deutsche Krebsforschungszentrum, with his expertise in isotope handling, chelation and labeling chemistry.

In 2003 Tuomo returned to his work for industry and joined evo-partners as an associate partner supporting client companies in the radio-pharmaceutical sector.